This helps explain something that has puzzled researchers for decades: why have nearly every drug designed to target and remove amyloid plaques failed to meaningfully reverse or halt Alzheimer’s disease? Because if the plaques are a symptom of an underlying metabolic problem, removing the plaques without addressing the root cause is like mopping the floor without turning off the faucet.